Daplyza®-MXR
Therapeutic Segment:
Anti-Diabetic
Generic Name:
Dapagliflozin + Metformin XR
Indication
Extended Release Tablets
- 5mg + 500mg
- 5mg + 1000mg
- 10mg + 500mg
- 10mg + 1000mg
Combination of Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor and Metformin, a biguanide indicated as an adjunct to diet & exercise to improve glycemic control in adults with type 2 diabetes mellitus.